Pulmocide
Targeted therapies for serious respiratory diseases
London, United Kingdom · Founded 2013 · $201.4M raised
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- pulmocide.com
- Total Funding
- $201.4M
- Last Round
- $30.4M Series BDec 2022
- Rounds
- 4
About
Pulmocide is a UK-based biopharmaceutical company developing novel inhaled therapies for difficult-to-treat respiratory diseases, with its lead program focused on pulmonary aspergillosis. Its investigational drug candidate, opelconazole, is a potent inhaled antifungal agent designed to deliver high, targeted drug concentrations directly to the lungs while minimizing systemic exposure, and is currently being evaluated in a Phase 3 clinical trial for patients unresponsive to standard antifungal treatment. Pulmocide was cofounded by Dr. Pete Strong, Dr. Garth Rapeport, Dr. Kazuhiro Ito, and Dr. John Murray.
Summary
Pulmocide is a Biotech company based in London, United Kingdom, founded in 2013. It has raised $201.4M in total across 4 rounds, most recently a $30.4M Series B round in Dec 2022. Investors include F-Prime Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2022
Sign up to see all 4 rounds
Series B through Extension Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pulmocide"><img src="https://indexed.vc/api/badge/company/pulmocide" alt="Pulmocide on Indexed.vc" width="260" height="76" /></a>